<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02902380</url>
  </required_header>
  <id_info>
    <org_study_id>4-2016-0644</org_study_id>
    <nct_id>NCT02902380</nct_id>
  </id_info>
  <brief_title>The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical stress induces stress hormone release and sympathetic hyperactivation.
      Dexmedetomidine has sympatholytic effect and attenuates stress responses. This study
      investigate the effect of dexmedetomidine on stress responses and autonomic nervous system
      balance in patients undergoing major spine surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 27, 2016</start_date>
  <completion_date type="Actual">July 1, 2017</completion_date>
  <primary_completion_date type="Actual">July 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stress hormone level</measure>
    <time_frame>immediately after anesthetic induction</time_frame>
    <description>The levels of stress hormone including epinephrine, norepinephrine, cortisol, and glucose will be measured during spinal surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress hormone level</measure>
    <time_frame>1 hour after start of surgery</time_frame>
    <description>The levels of stress hormone including epinephrine, norepinephrine, cortisol, and glucose will be measured during spinal surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress hormone level</measure>
    <time_frame>2-hour after start of surgery</time_frame>
    <description>The levels of stress hormone including epinephrine, norepinephrine, cortisol, and glucose will be measured during spinal surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress hormone level</measure>
    <time_frame>1 second after the end of surgery</time_frame>
    <description>The levels of stress hormone including epinephrine, norepinephrine, cortisol, and glucose will be measured during spinal surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress hormone level</measure>
    <time_frame>1 hour after the end of surgery</time_frame>
    <description>The levels of stress hormone including epinephrine, norepinephrine, cortisol, and glucose will be measured during spinal surgery.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine infusion (0.4 mcg/kg/h) from immediately after anesthetic induction to end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% saline infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine group</intervention_name>
    <description>dexmedetomidine infusion (0.4 mcg/kg/h) from immediately after anesthetic induction to end of surgery</description>
    <arm_group_label>Dexmedetomidine Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>control group</intervention_name>
    <description>0.9% saline infusion</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient between 20 and 70 of age with ASA physical status Ⅰ-Ⅲ

          -  patient scheduled for major spine surgery

        Exclusion Criteria:

          -  ASA physical status Ⅳ

          -  congestive heart failure

          -  severe hepatorenal disease

          -  insulin dependent DM(diabetes mellitus)

          -  cancer or metastasis

          -  pregnancy

          -  problem with communication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2016</study_first_submitted>
  <study_first_submitted_qc>September 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2016</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

